Probes and cocktails for drug-drug interaction evaluation : the future is microdosing?

enthalten in: Clinical pharmacology & therapeutics | 12 February 2019

von Mikus, G.

Methodological considerations on CYP2D6 phenoconversion due to drug-drug interaction

enthalten in: Clinical pharmacology & therapeutics | 10 February 2019

von Ziesenitz, V. | Mikus, G.

The NTCP-inhibitor Myrcludex B : effects on bile acid disposition and tenofovir pharmacokinetics

enthalten in: Clinical pharmacology & therapeutics | 2018

von Blank, A. | Eidam, A. | Hohmann, N. | +8

CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers

in: Clinical pharmacology & therapeutics | 2014

von Markert, C. | Burhenne, J. | Weiß, J. | +2

Response to "Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?" : Evaluation of CYP3A activity with microdoses of midazolam

enthalten in: Clinical pharmacology & therapeutics | 6 February 2014

von Hohmann, N. | Halama, B. | Siller, N. | +2

A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions

enthalten in: Clinical pharmacology & therapeutics | 20 March 2013

von Halama, B. | Hohmann, N. | Burhenne, J. | +3

Cytochrome P450-3A phenotyping using Midazolam is not altered by OATP1B1 polymorphisms

enthalten in: Clinical pharmacology & therapeutics | 28 February 2013

von Ziesenitz, V. | Weiß, J. | Haefeli, W. | +1

Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using a limited sampling strategy

enthalten in: Clinical pharmacology & therapeutics | 21 September 2011

von Katzenmaier, S. | Markert, C. | Riedel, K. | +3

Effect of simultaneous induction and inhibition of CYP3A by St John's wort and ritonavir on CYP3A activity

enthalten in: Clinical pharmacology & therapeutics | 2010

von Hafner-Blumenstiel, V. | Jäger, M. | Matthée, A. | +4

Pharmacokinetics of 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol (CTHC) After Intravenous Administration of CTHC in Healthy Human Subjects

enthalten in: Clinical pharmacology & therapeutics | 2007

von Glaz-Sandberg, A. | Dietz, L. | Nguyen, H. | +3